Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer

Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer

Background: Small cell lung cancer (SCLC) has a poor prognosis, and its treatment options are limited. Delta-like protein 3 (DLL3) is expressed specifically in SCLC and is considered a promising therapeutic target for patients with this disease. Rovalpituzumab tesirine (Rova-T) was the first antibod...

Full description

Bibliographic Details
Main Authors: Yoshitaka Isobe, Kazuhide Sato, Yuko Nishinaga, Kazuomi Takahashi, Shunichi Taki, Hirotoshi Yasui, Misae Shimizu, Rena Endo, Chiaki Koike, Noriko Kuramoto, Hiroshi Yukawa, Shota Nakamura, Takayuki Fukui, Koji Kawaguchi, Toyofumi F. Chen-Yoshikawa, Yoshinobu Baba, Yoshinori Hasegawa
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396420300074

Internet

http://www.sciencedirect.com/science/article/pii/S2352396420300074

Similar Items